| Previous Close | 1.9100 |
| Open | 0.0000 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 0.0000 - 0.0000 |
| 52 Week Range | |
| Volume | 0 |
| Avg. Volume | 44,120 |
| Market Cap | 40.779M |
| Beta (3Y Monthly) | -1.58 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.22 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
DENVER, CO / ACCESSWIRE / February 19, 2019 / AmeriCann, Inc. (OTCQB: ACAN), a cannabis company that is developing cultivation, processing and manufacturing facilities, commented on the impact of newly appointed U.S. Attorney General William Barr and the positive outlook for federal cannabis legislation. "Based on the overwhelming public support for cannabis in the country, it is not a question of if cannabis prohibition at the federal level will end, but rather a matter of when it is repealed," says AmeriCann CEO Tim Keogh.
Construction of the MMCC project is moving forward rapidly, with millions of dollars already invested in site preparation, concrete, and steelwork. The entire building will be 100% leased by an existing, vertically-integrated Massachusetts operator Bask, Inc. The Building 1 project cost is $7,500,000 and is expected to create 30 new direct jobs in the area. The state-of-the-art greenhouse is scheduled to be erected in February adjoining the topped off building, with a completion date for the facility in summer 2019.
DENVER, CO / ACCESSWIRE / January 14, 2019 / AmeriCann, Inc. (OTCQB: ACAN), a cannabis company that is developing state-of-the-art product manufacturing and greenhouse cultivation facilities, announced today that Tim Keogh, CEO, will be a featured presenter at the second annual Benzinga Cannabis Capital Conference to be held in Miami, Florida on Wednesday, January 16. Mr. Keogh will be providing an update on AmeriCann's flagship project the Massachusetts Medical Cannabis Center, the progress of AmeriCann Brands - the Company's extraction and CPG business, and expansion plans as a multi-state operator. AmeriCann's presentation will be at 10:40am in Ballroom 3 at Eden Roc Hotel at 4525 Collins Avenue, Miami Beach, FL.
With the previous presidential administration’s frankness on the matter, marijuana has become more blasé. Naturally, marijuana stocks have also increased in popularity, where we have more choices today than was previously thought possible. For instance, some of the top marijuana stocks are levered toward medical cannabis.
DENVER, CO / ACCESSWIRE / December 18, 2018 / AmeriCann, Inc. (OTCQB: ACAN), a cannabis company that is developing sustainable cultivation, processing and manufacturing facilities provided an update on construction and Adult-Use sales in Massachusetts. AmeriCann has commenced construction on the Massachusetts Medical Cannabis Center (MMCC) on a 52-acre parcel located in Southeastern Massachusetts.
DENVER, CO / ACCESSWIRE / November 29, 2018 / AmeriCann, Inc. (OTCQB: ACAN ), a specialized cannabis company that is developing state-of-the-art product manufacturing and greenhouse cultivation facilities, ...
DENVER, CO / ACCESSWIRE / November 20, 2018 / AmeriCann, Inc. (OTCQB: ACAN), a cannabis company that is developing cultivation, processing and manufacturing facilities announces the commencement of Adult-Use sales in Massachusetts. Adults over 21 years of age now have a safe, legal market to purchase laboratory tested cannabis and cannabis products in Massachusetts. Industry experts believe that the Massachusetts adult-use market, in conjunction with its existing medical program, will exceed $1 billion annually generating hundreds of millions in taxes for the Commonwealth.
DENVER, CO / ACCESSWIRE / November 14, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an agricultural-technology company that is developing the next generation of eco-friendly state-of-the-art greenhouse cannabis cultivation and processing properties, announced today the formation of AmeriCann Brands, Inc. a wholly owned subsidiary for the purpose of obtaining a Consumer Packaged Goods (CPG) manufacturing license in Massachusetts. AmeriCann Brands will manufacture both branded and white-label cannabis products at the Massachusetts Medical Cannabis Center (MMCC) upon the grant of a license.
DENVER, CO / ACCESSWIRE / November 8, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an agricultural-technology company that is developing the next generation of eco-friendly state-of-the-art greenhouse cannabis cultivation and processing properties, today provided commentary on the impact of the recent developments in Washington, D.C. and the outlook for the cannabis industry. U.S. Attorney General Jeff Sessions, an outspoken critic of the cannabis industry, has resigned a day after the Midterm elections. Congressman Pete Sessions was defeated in his re-election bid for Texas' 32nd Congressional District.
Company Plans to Own and Operate Large-Scale Extraction and Product Manufacturing Facility in 2nd Building to Produce Branded Cannabis Beverages, Vaporizer Products, Edible and Non-Edible Products and ...
DENVER, CO / ACCESSWIRE / October 4, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an agricultural-technology company that is developing the next generation of eco-friendly start-of-the-art greenhouse cannabis cultivation and processing properties, has announced plans to own and operate a large-scale cannabis manufacturing and processing facility at its 52-acre Massachusetts Medical Cannabis Center (MMCC) in Freetown, MA. The company has commenced construction on the first phase of the MMCC and recently released designs for the second phase. The second phase includes AmeriCann's manufacturing facility which is designed to provide support to the entire MMCC project, as well as to other licensed cannabis cultivators throughout Massachusetts.
DENVER, CO / ACCESSWIRE / September 21, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an Agricultural-Technology company that is developing state-of-the-art greenhouse cannabis cultivation and processing properties, announced today that CEO Tim Keogh will be speaking at the Cannabis Community Care and Research Network's (C3RN) Cannabis Science and Education Series on Sunday, September 23 in Boston, MA. The event is part of C3RN's monthly Cannabis Science, Education, and Networking series in Massachusetts to showcase the latest cannabis innovations. The events attract diverse groups of leaders from within and outside of the cannabis industry, public health and policy experts and other businesses.
DENVER, CO / ACCESSWIRE / September 12, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an agricultural-technology company that is developing the next generation of eco-friendly start-of-the-art greenhouse cannabis cultivation and processing properties, plans to host a ground breaking celebration for its Massachusetts Medical Cannabis Center (MMCC) on Tuesday, September 25. AmeriCann designed the MMCC on a 52-acre parcel located in Freetown, Mass. The project allows for 987,000 sq. ft. of cannabis cultivation and processing infrastructure and will be developed in three phases. The ground breaking event will celebrate the first phase of the MMCC construction which will be a 30,000 sq. ft. cannabis cultivation, processing and research facility.
DENVER, CO / ACCESSWIRE / August 23, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an agricultural-technology company that is developing the next generation of eco-friendly state-of-the-art greenhouse cannabis cultivation and processing properties, announced today that it has engaged Teak Media + Communication to support the Company's public relations programs. Teak Media + Communication will deploy a comprehensive communications program aimed at increasing awareness of AmeriCann and its accomplishments. "Teak Media's track record of success in increasing awareness for public companies is impressive," stated AmeriCann founder Ben Barton.
DENVER, CO / ACCESSWIRE / July 18, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an agricultural-technology company that is developing the next generation state-of-the-art greenhouse cannabis cultivation and processing properties, announced today that it has closed an all equity financing offering with total proceeds of $3,819,000. The proceeds from the $3.00 per share equity financing will be used for construction at the Company's Massachusetts Medical Cannabis Center (the "MMCC") development.
DENVER, CO / ACCESSWIRE / July 9, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an agricultural-technology company that is developing the next generation of eco-friendly state-of-the-art greenhouse cannabis cultivation and processing properties, announced today that it is leading a research pilot study in Massachusetts. The research is led by Cannabis Community Care and Research Network (C3RN) in collaboration with UMass Dartmouth. AmeriCann, through its Preferred Partner BASK, Inc. ("BASK"), is conducting research studies with C3RN who is now collaborating with the UMass Dartmouth Charlton College of Business.
DENVER, CO / ACCESSWIRE / June 28, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an Agricultural-Technology company that is developing the next generation of eco-friendly state-of-the-art greenhouse cannabis cultivation and processing properties, announced today that CEO Tim Keogh will be speaking at Cannabis Community Care and Research Network's (C3RN) Cannabis Science and Education Series on Thursday, June 28 in Worcester, MA. The event is part of C3RN's monthly Cannabis Science, Education, and Networking series in Massachusetts to showcase the latest cannabis innovations. The events attract diverse groups of leaders from within and outside of the cannabis industry, public health and policy experts and other businesses.
DENVER, CO / ACCESSWIRE / June 20, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an Agricultural-Technology company that is developing the next generation of eco-friendly state-of-the-art greenhouse cannabis cultivation and processing properties, announced today that it is formally partnering with Cannabis Community Care and Research Network (C3RN), a Massachusetts-based public benefit corporation focused on cannabis research and technology. C3RN is collaborating with leading academic institutions, data scientists, the cannabis industry, and healthcare providers to conduct rigorous cannabis research studies and to implement evidence-based findings into practice. AmeriCann, through its Preferred Partner BASK, Inc. ("BASK"), will design and conduct research studies with C3RN and its academic and healthcare partners to better understand the therapeutic benefits of cannabis and improve product offerings including AmeriCann's Solanna line of products.
DENVER, CO / ACCESSWIRE / June 19, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an Agricultural-Technology company that is developing the next generation of eco-friendly state-of-the-art greenhouse style cannabis cultivation and processing properties, announced today that CEO Tim Keogh will be speaking at State House News Forum "Massachusetts' Expanding Cannabis Economy" held in Boston, MA, on Wednesday, June 26, starting at 8am ET. Mr. Keogh will be speaking about the expanding cannabis industry's statewide potential, including investment, job growth, tax revenue, real estate and tourism. Tim Keogh, AmeriCann CEO, has spoken at cannabis industry conferences across the United States as an expert on topics including industry best practices, real estate development and the cannabis economy.
DENVER, CO / ACCESSWIRE / June 12, 2018 / AmeriCann, Inc. (OTCQB: ACAN), Today AmeriCann, an Agricultural-Technology company that is developing the next generation of sustainable, state-of-the-art cannabis cultivation properties, was recognized for creating the most positive impact for its workers based on an independent, comprehensive assessment administered by the nonprofit B Lab. Honorees are featured on B the Change, the digital Medium publication produced by B Lab, at bthechange.com/bestfortheworld. AmeriCann is honored in the Best For Workers list, which includes businesses that earned a Workers score in the top 10 percent of more than 2,400 Certified B Corporations on the B Impact Assessment.
Between Senate Minority Leader Chuck Schumer announcing plans to introduce legislation that would decriminalize cannabis on a federal level, and Michigan adding recreational cannabis to its November ballot, things have been looking up for the industry. Of course with a market as speculative as cannabis, there are always going to be outperformers and underperformers, regardless of the macro picture. The charts below are courtesy of VantagePoint, a platform that uses Artificial Intelligence and machine learning to forecast future price movements 1-3 days in advance with up to 86 percent accuracy.
DENVER, CO / ACCESSWIRE / May 23, 2018 / AmeriCann, Inc. (OTCQB: ACAN), an Agricultural-Technology company that is developing the next generation of eco-friendly state-of-the-art greenhouse style cannabis cultivation and processing properties, announced that its Preferred Partner in Massachusetts, Bask, Inc. ("BASK" of "BASK Premium Cannabis"), hosted a ribbon cutting ceremony. BASK held the grand opening event at its medical marijuana dispensary in Fairhaven, MA on May 22, 2018. AmeriCann formed an alliance with BASK as a Preferred Partner in Massachusetts in 2016 and BASK is scheduled to be the first business to operate in AmeriCann's Massachusetts Medical Cannabis Center ("MMCC").
DENVER, CO / ACCESSWIRE / April 20, 2018 / GVC Capital LLC ("GVC") and Dave Lavigne at Trickle Research LLC ("Trickle Research") will host the Rocky Mountain MicroCap Conference II ...
Recent News Regarding Unprecedented Political Support from President Trump Seen as a Significant Advancement DENVER, CO / ACCESSWIRE / April 17, 2018 / AmeriCann, Inc. (OTCQB: ACAN ), an Agricultural-Technology ...